association omega num fatty acid supplementation risk major cardiovascular disease events systematic review meta-analysis pubmed ncbi abstract context considerable controversy exists association omega num polyunsaturated fatty acids pufas major cardiovascular end points objective assess role omega num supplementation major cardiovascular outcomes data sources medline embase cochrane central register controlled trials august num study selection randomized clinical trials evaluating effect omega num all-cause mortality cardiac death sudden death myocardial infarction stroke data extraction descriptive quantitative information extracted absolute relative risk rr estimates synthesized random-effects model heterogeneity assessed statistic num subgroup analyses performed presence blinding prevention settings patients implantable cardioverter-defibrillators meta-regression analyses performed omega num dose statistical significance threshold num assumed adjustment multiple comparisons data synthesis num citations retrieved num studies num patients included reporting num deaths num cardiac deaths num sudden deaths num myocardial infarctions num strokes statistically significant association observed all-cause mortality rr num num ci num num risk reduction num num ci num num cardiac death rr num num ci num num num num ci num num sudden death rr num num ci num num num num ci num num myocardial infarction rr num num ci num num num num ci num num stroke rr num num ci num num num num ci num num supplement studies considered conclusion omega num pufa supplementation lower risk all-cause mortality cardiac death sudden death myocardial infarction stroke based relative absolute measures association 
